About Us

Our Clinical Trials Unit

The Barts CTU coordinates the ACT programme (Advancing substantial improvements in health through optimally designed Clinical Trials) which aims to contribute to a reduction in mortality and morbidity from major disease through effective, efficient clinical trials. The main objective is to provide a centre of excellence for clinical trials research to successfully develop and conduct high quality evaluation of health interventions.

The Barts CTU obtained registration with the [UK Clinical Research Collaboration (UKCRC)]  in 2007 and receives infrastructure funding through the ACT programme from Barts Charity.

Our Work

The Barts CTU has a long-standing portfolio of cancer prevention and screening studies including several high-profile pivotal large-scale multi-centre international trials.  The current cancer prevention portfolio includes: 

• Multi-centre observational studies using remote decision aid tools and saliva sampling for genetic testing.
• Multi-centre observational studies evaluating optimal self-sampling methods for cancer screening programs.
• Studies incorporating behavioural interventions in cancer prevention and screening.
• Bio-specimen collection studies to analyse for predictors for recurrence post-surgery, and for future potential biomarker discovery and validation.
• Long-term follow-up of participants using national registries.

Contact Us

For general enquiries or questions about the Barts Clinical Trials Unit, please contact us at Bartsctu@qmul.ac.uk.

Our team will be happy to assist and direct your query to the appropriate area.

Our Sub-Units